About John Talley
John Talley is a chief executive officer and director at Mitotherapeutix.
John Talley first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name John Talley in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people John Talley works with at each company, as listed on that company's latest Form D.
Mitotherapeutix, LLC · Form D/A, May 22, 2025
Fenel Eloi
Director
RH
Robert Hemley
Executive officer and director
RH
Robert Hennessey
Executive officer and director
DW
Daniel Wagner
Director